Table 2 The survival Rate of Proliferation of MKN45 gastric Cells by Baicalin Combined with VCR, ADM, and 5-FU Intervention (\({\overline{\text{x}}}\) ± s, n = 6, %).
Groups | Control | 0.01 × PPC | 0.1 × PPC | 1 × PPC | 10 × PPC | 100 × PPC |
|---|---|---|---|---|---|---|
ADM | 100 ± 4.52 | 96.14 ± 10.28 | 87.44 ± 5.77 | 63.66 ± 2.46 | 67.11 ± 5.51 | 47.61 ± 3.51 |
ADM + Baicalin 200uM | 100 ± 3.67 | 63.62 ± 3.93a | 61.24 ± 4.38a | 56.25 ± 1.88a | 45.64 ± 3.21a | 29.83 ± 5.17a |
5-FU | 100 ± 1.56 | 84.38 ± 7.24 | 78.89 ± 3.74 | 75.55 ± 1.91 | 69.43 ± 1.7 | 39.68 ± 3.17 |
5-FU + Baicalin 200uM | 100 ± 2.14 | 65.06 ± 8.78a | 58.84 ± 2.26a | 56.58 ± 3.11a | 49.22 ± 4.12a | 33.79 ± 3.67a |
VCR | 100 ± 1.54 | 72.93 ± 2.15 | 50.73 ± 2.36 | 41.7 ± 1.78 | 36.37 ± 2.59 | 24.13 ± 3.49 |
VCR + Baicalin 200uM | 100 ± 3.49 | 56.15 ± 3.2a | 38.63 ± 1.18a | 34 ± 2.71a | 27.96 ± 3.29a | 15.91 ± 2.21a |